Remote monitoring for people on long-term oxygen therapy
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests if monitoring your vital signs remotely (like oxygen levels and heart rate) can help improve care for people who need long-term oxygen therapy due to COPD or ILD. It may help you feel more supported at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with COPD or ILD (chronic lung diseases).
- You are 18 years or older.
- Your condition has been stable (no flare-ups or hospital stays) for at least 6 weeks.
- You are already on the best possible medicines and use long-term home oxygen.
- You have a smartphone that works with the study's monitoring device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if people with COPD can use a home monitoring system after a flare-up to help doctors track their recovery. It aims to reduce hospital visits and improve care.
This trial tests a device that tracks how often you use your home oxygen therapy. It is for people with COPD who use oxygen continuously at home and have been medically stable for at least 6 weeks.
This trial tests a new portable oxygen device to help people with lung disease stay active without running out of breath. It compares how well the device works during daily activities.
This study looks at whether regular video check-ins and remote monitoring from your care team can improve your breathing and quality of life compared to the usual routine check-ups, for people with COPD who need a breathing machine at home.
This study tests a home monitoring program to help people with COPD stay healthier. You will use a device to measure your breathing and answer questionnaires. This may help catch problems early.
This trial tests whether home telemonitoring combined with a breathing machine (non-invasive ventilation) can help people with advanced COPD and persistently high carbon dioxide levels. It aims to improve care and reduce hospital visits.
Hear when a new ILD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.